triamcinolone acetonide has been researched along with Choroid Neovascularization in 116 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (1.72) | 18.2507 |
| 2000's | 87 (75.00) | 29.6817 |
| 2010's | 26 (22.41) | 24.3611 |
| 2020's | 1 (0.86) | 2.80 |
| Authors | Studies |
|---|---|
| Maggio, E; Mete, M; Parrozzani, G; Pertile, G; Polito, A | 1 |
| Fine, HF; Grossniklaus, HE; Prenner, JL; Reshef, ER; Roth, DB; Shah, SP | 1 |
| Chen, Y; Gao, Y; Hong, F; Lin, L; Sun, X; Zhang, K; Zhong, Q | 1 |
| Ali, MH; Goerlitz-Jessen, M; Grewal, DS | 1 |
| Geltzer, A; Turalba, A; Vedula, SS | 2 |
| Guthrie, MJ; Kang-Mieler, JJ; Mieler, WF; Osswald, CR; Valio, NL | 1 |
| Hayashi, T; Kohno, H; Ohkuma, Y; Sakai, T; Tsuneoka, H; Watanabe, A | 1 |
| Hara, H; Kizaka-Kondoh, S; Kuchimaru, T; Masuda, T; Nagasawa, H; Nakamura, S; Shimazawa, M; Takata, S; Tsuruma, K | 1 |
| Saperstein, DA; Singh, CN | 1 |
| Bunse, A; Frimpong-Boateng, A; Roider, J; Rüfer, F | 1 |
| Michels, S; Polak, K; Sacu, S; Schmidt-Erfurth, U; Varga, A; Vécsei-Marlovits, PV; Weigert, G | 1 |
| Brue, C; Chang, LK; Freund, KB; Klancnik, JM; Slakter, JS; Spaide, RF | 1 |
| Criswell, MH; Hu, WZ; Li, R; Margaron, P; Steffens, TJ | 1 |
| Goebel, W; Guthoff, R | 1 |
| Gotoh, N; Iwama, D; Otani, A; Sasahara, M; Tamura, H; Tsujikawa, A; Yodoi, Y; Yoshimura, N | 1 |
| Lo Giudice, G; Maritan, V; Midena, E; Piermarocchi, S; Sartore, M; Segato, T | 1 |
| Aue, A; Lie, S; Polak, K; Sacu, S; Schmidt-Erfurth, U; Simader, C | 1 |
| Gosławski, W; Karczewicz, D; Lubiński, W; Mozolewska-Piotrowska, K; Szych, Z | 1 |
| Amat, P; Lugo, FL; Montero, JA; Ruiz-Moreno, JM | 1 |
| Ishikawa, K; Ito, Y; Kondo, M; Nishihara, H; Ozawa, S; Piao, CH; Terasaki, H | 1 |
| Adam, A; Bartz-Schmidt, KU; Boeyden, V; Claes, C; Eckardt, C; Eckert, T; Grisanti, S; Kaiserling, E; Pertile, G; Scharioth, GB; Shinoda, K; Szurman, P; Tatar, O; Yoeruek, E | 1 |
| Bakri, SJ; Edwards, AO; Pulido, JS; Risco, M | 1 |
| Gomi, F; Hamasaki, T; Ikuno, Y; Tano, Y; Wakabayashi, T | 1 |
| Haeussler-Sinangin, Y; Koch, FH; Koss, MJ; Scholtz, S; Singh, P | 1 |
| Maberley, D | 1 |
| Dunavoelgyi, R; Pruente, C; Sacu, S; Schmidt-Erfurth, U; Simader, C | 1 |
| Hatta, Y; Ishikawa, K; Ito, Y; Nishihara, H; Ozawa, S; Terasaki, H | 1 |
| Baklouti, K; Bouraoui, R; Chebil, A; el Matri, L; Kort, F; Mghaieth, F | 1 |
| Baillif-Gostoli, S; Mauget-Faÿsse, M; Quaranta-El Maftouhi, M | 1 |
| Kimura, H; Kuroda, S; Toyokawa, N | 1 |
| Hajouli, N; Hiesch, A; Quintyn, JC | 1 |
| Kim, SJ; Toma, HS | 1 |
| Barnett, JM; Kim, SJ; Penn, JS; Toma, HS | 1 |
| Behar-Cohen, F; Torriglia, A; Valamanesh, F | 1 |
| Gale, J; Hollands, H; Hollands, S; Seif, G | 1 |
| Arcidiacono, B; Becerra, EM; Danzi, P; Gandolfo, F; Morescalchi, F; Nascimbeni, G; Semeraro, F | 1 |
| Cennamo, G; Cesarano, I; D'Amico, G; De Crecchio, G; Finelli, M; Forte, R | 1 |
| Bardak, Y; Cekiç, O; Yeşildağ, A | 1 |
| Bidot, ML; Bidot, S; Bron, A; Creuzot-Garcher, C; Malvitte, L | 1 |
| Bandello, F; Giatsidis, S; Introini, U; Scotti, F; Setaccioli, M; Torres Gimeno, A | 1 |
| Edelhauser, HF; Kadam, RS; Kompella, UB; Tyagi, P | 1 |
| Lanzetta, P; Sarao, V; Veritti, D | 1 |
| Holz, FG; Miller, DW | 1 |
| Billson, F; Chua, W; Gillies, MC; Hunyor, AB; Luo, W; Mitchell, P; Penfold, P; Simpson, JM | 1 |
| Ciulla, TA; Cox, TA; Criswell, MH; Csaky, KG; Danis, RP; Fronheiser, M; Robinson, MR; Yuan, P | 1 |
| Maranan, L; Sorenson, J; Spaide, RF | 3 |
| Allen, VD; Danis, RP; Harris, A; Pratt, LM; Rechtman, E; Speicher, MA | 1 |
| Akkoyun, I; Budde, WM; Degenring, RF; Jonas, JB; Kreissig, I | 1 |
| Billson, FA; Chua, W; Gillies, MC; Hunyor, AB; Luo, W; Mitchell, P; Penfold, P; Simpson, JM; Zhu, M | 1 |
| Lai, WW; Shapiro, MJ; Sharma, MC | 1 |
| Asano, Y; Hida, T; Kojima, E; Okada, AA; Wakabayashi, T | 1 |
| Dunbar, MT; Hunter, MA; Rosenfeld, PJ | 1 |
| Kolluru, C; Ramasamy, K; Vedantham, V | 1 |
| Arevalo, JF; Garcia, RA; Mendoza, AJ | 1 |
| Kato, A; Kimura, H; Kunou, N; Nozaki, M; Ogura, Y; Okabe, J; Okabe, K | 1 |
| Akar, Y; Barile, GR; Cekiç, O; Chang, S; Schiff, WM; Tseng, JJ | 1 |
| Harder, B; Jonas, JB; Kamppeter, BA; Spandau, UH; Vossmerbaeumer, U | 1 |
| Arevalo, JF; Fernández, CF; Mendoza, AJ | 1 |
| Reichle, ML | 1 |
| Ho, T; Potter, MJ; Szabo, SM | 1 |
| Degenring, RF; Jonas, JB | 1 |
| Kak, R; Mitchell, KW; Sandhu, SS; Talks, SJ; Van de Moere, A | 1 |
| Agurto-Rivera, R; Colina-Luquez, J; Diaz-Rubio, J; Fromow-Guerra, J; Jager, RD; Macky, TA; Martinez-Jardon, S; Papa-Oliva, G; Quiroz-Mercado, H; Torres-Bernal, L | 1 |
| Binder, S; Krebs, I; Stolba, U | 1 |
| Augustin, AJ; Schmidt-Erfurth, U | 2 |
| Coupland, SG; Kertes, PJ | 1 |
| Calabria, G; Cicinelli, S; Ghiglione, D; Lai, S; Nasciuti, F; Nicolò, M | 1 |
| Jonas, JB | 1 |
| Harder, B; Jonas, JB; Kamppeter, BA; Spandau, UH | 1 |
| Aue, A; Geitzenauer, W; Michels, S; Sacu, S; Schmidt-Erfurth, U; Simader, C | 1 |
| Gomi, F; Ikuno, Y; Kamei, M; Kim, A; Oji, M; Oshima, Y; Sakaguchi, H; Tano, Y | 1 |
| Morescalchi, F; Ratiglia, R; Staurenghi, G; Viola, F | 1 |
| Augustin, A; Michels, S; Schmidt-Erfurth, U | 1 |
| Zarbin, M | 1 |
| Ansari-Shahrezaei, S; Ergun, E; Krepler, K; Maár, N; Stur, M; Wedrich, A; Wimpissinger, B | 1 |
| Fernandez, M; Gomez-Ulla, F; Marticorena, J; Pazos, B; Rodriguez-Cid, MJ; Sanchez-Salorio, M | 1 |
| Ho, TC; Lai, WW | 1 |
| Aslan, O; Batman, C; Berker, N; Elgin, U; Ozkan, SS | 1 |
| Bandello, F; Chakravarthy, U; Chong, V; Creuzot-Garcher, C; Dimitrakos, SA; Korobelnik, JF; Larsen, M; Monés, J; Pauleikhoff, D; Pournaras, CJ; Soubrane, G; Staurenghi, G; Virgili, G; Wolf, S | 1 |
| Dhalla, MS; Shah, GK; Shepherd, JB; Tewari, A | 1 |
| Chan, WM; Lai, TY; Lam, DS; Liu, DT; Wong, AL | 1 |
| Arias, L; Badia, M; Garcia-Arumi, J; Pujol, O; Ramon, JM; Rubio, M | 2 |
| Futagami, S; Kojima, A; Mochizuki, M; Ohno-Matsui, K; Shimada, N; Tokoro, T | 1 |
| Das, T; Hussain, N; Kallukuri, SB; Khanna, R; Mohan Ram, LS; Rawal, H | 1 |
| Chaudhry, NA; Colina, J; Haffner, G; Liggett, PE; Tom, D | 1 |
| Montero, JA; Ruiz-Moreno, JM | 1 |
| Gomi, F; Nishida, K; Oshima, Y; Sakaguchi, H; Sawa, M; Tano, Y; Tsujikawa, M | 1 |
| Bamonte, G; Centola, M; Fasolino, G; Patelli, F; Petroni, S | 1 |
| Cheng, L; Falkenstein, I; Freeman, WR; Kozak, I; Tammewar, AM | 1 |
| Behar-Cohen, F; BenEzra, D; Doat, M; Dot, C; Jeanny, JC; Jonet, L; May, F | 1 |
| Apte, RS; Kymes, SM; Schadlu, R | 1 |
| Arevalo, JF; Berrocal, MH; Garcia, RA; Garcia-Amaris, R; Novoa, LA; Rodríguez, A; Rodriguez, FJ; Sanchez, JG; Wu, L | 1 |
| Jonas, JB; Wang, D; Xu, L; Zhang, X; Zhu, X | 1 |
| Binder, S; Goll, A; Krebs, I; Krepler, K; Stolba, U | 1 |
| Inoue, Y; Iriyama, A; Obata, R; Takahashi, H; Tamaki, Y; Yanagi, Y | 1 |
| Bressler, NM; Gilson, MM; Jabs, DA; Solomon, SD; Thorne, JE; Wilson, DJ | 1 |
| Chen, FK; Kennedy, C | 1 |
| Bortolotto, C; Farah, M; Nóbrega, M | 1 |
| Chaudhary, V; Hooper, PL; Mao, A; Sheidow, TG | 1 |
| Chan, WM; Lai, TY; Lam, DS; Lau, TT; Lee, VY; Liu, DT | 1 |
| Bartz-Schmidt, KU; Eckardt, C; Grisanti, S; Kaiserling, E; Mohr, A; Pertile, G; Shinoda, K; Szurman, P; Tatar, O; Yoeruek, E | 1 |
| Chen, MS; Ho, TC; Lee, YA; Yang, CH; Yang, CM | 1 |
| Allingham, RR; Fekrat, S; Im, L; Singh, I; Stinnett, S | 1 |
| Nehemy, MB; Nehemy, PG; Schachat, AP; Vasconcelos-Santos, DV | 1 |
| Billson, FA; Challa, JK; Gillies, MC; Gyory, JF; Hunyor, AB; Penfold, PL | 1 |
| Anliker, W; Ciulla, TA; Danis, RP; Pratt, LM | 1 |
| Ciulla, TA; Criswell, MH; Danis, RP; Hill, TE | 1 |
| Billson, FA; Gyory, J; Penfold, PL; Wong, JG | 1 |
| Eichler, W; Friedrichs, U; Hoffmann, S; Wang, YS; Wiedemann, P | 1 |
| Billson, FA; Gyory, JF; Hunyor, AB; Penfold, PL | 1 |
8 review(s) available for triamcinolone acetonide and Choroid Neovascularization
| Article | Year |
|---|---|
Surgical implantation of steroids with antiangiogenic characteristics for treating neovascular age-related macular degeneration.
Topics: Angiogenesis Inhibitors; Choroidal Neovascularization; Drug Implants; Humans; Macular Degeneration; Photochemotherapy; Pregnadienediols; Randomized Controlled Trials as Topic; Triamcinolone Acetonide | 2013 |
On the retinal toxicity of intraocular glucocorticoids.
Topics: Animals; Anti-Inflammatory Agents; Cell Death; Choroidal Neovascularization; Endothelium, Vascular; Glucocorticoids; Humans; Intravitreal Injections; Macular Edema; Retina; Retinal Diseases; Retinal Neovascularization; Triamcinolone Acetonide | 2010 |
Clinical evidence of intravitreal triamcinolone acetonide in the management of age-related macular degeneration.
Topics: Angiogenesis Inhibitors; Animals; Anti-Inflammatory Agents; Blindness; Choroidal Neovascularization; Combined Modality Therapy; Delayed-Action Preparations; Humans; Hyperthermia, Induced; Intravitreal Injections; Macular Degeneration; Photochemotherapy; Photosensitizing Agents; Porphyrins; Triamcinolone Acetonide; Vascular Endothelial Growth Factors; Verteporfin; Wet Macular Degeneration | 2011 |
[Pharmacological therapy for age-related macular degeneration. Current developments and perspectives].
Topics: Adrenal Cortex Hormones; Angiogenesis Inhibitors; Animals; Anti-Inflammatory Agents; Choroidal Neovascularization; Clinical Trials as Topic; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Disease Models, Animal; Endothelial Growth Factors; Eye Proteins; Fluorescein Angiography; Fundus Oculi; Haplorhini; Humans; Intercellular Signaling Peptides and Proteins; Lymphokines; Macular Degeneration; Matrix Metalloproteinase Inhibitors; Nerve Growth Factors; Neuroprotective Agents; Photochemotherapy; Placebos; Proteins; Rats; Serpins; Time Factors; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors; Visual Acuity | 2003 |
Intravitreal triamcinolone acetonide for treatment of intraocular oedematous and neovascular diseases.
Topics: Choroidal Neovascularization; Diabetic Retinopathy; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Degeneration; Macular Edema; Ocular Hypertension; Triamcinolone Acetonide; Vitreous Body | 2005 |
Perspectives on verteporfin therapy combined with intravitreal corticosteroids.
Topics: Choroidal Neovascularization; Combined Modality Therapy; Glucocorticoids; Humans; Injections; Macular Degeneration; Photochemotherapy; Photosensitizing Agents; Porphyrins; Triamcinolone Acetonide; Verteporfin; Vitreous Body | 2006 |
Should corticosteroids be considered as part of the standard care with photodynamic therapy?
Topics: Choroidal Neovascularization; Combined Modality Therapy; Delivery of Health Care; Glucocorticoids; Humans; Injections; Macular Degeneration; Photochemotherapy; Photosensitizing Agents; Porphyrins; Triamcinolone Acetonide; Verteporfin; Vitreous Body | 2006 |
Surgical implantation of steroids with antiangiogenic characteristics for treating neovascular age-related macular degeneration.
Topics: Angiogenesis Inhibitors; Choroidal Neovascularization; Drug Implants; Humans; Macular Degeneration; Pregnadienediols; Randomized Controlled Trials as Topic; Triamcinolone Acetonide | 2007 |
24 trial(s) available for triamcinolone acetonide and Choroid Neovascularization
| Article | Year |
|---|---|
Three-year visual outcome of photodynamic therapy plus intravitreal bevacizumab with or without subtenon triamcinolone acetonide injections for polypoidal choroidal vasculopathy.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Choroidal Neovascularization; Coloring Agents; Combined Modality Therapy; Drug Therapy, Combination; Female; Fluorescein Angiography; Follow-Up Studies; Glucocorticoids; Humans; Indocyanine Green; Intravitreal Injections; Male; Middle Aged; Photochemotherapy; Polyps; Retrospective Studies; Tenon Capsule; Tomography, Optical Coherence; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity | 2014 |
Reduced fluence versus standard photodynamic therapy in combination with intravitreal triamcinolone: short-term results of a randomised study.
Topics: Aged; Choroidal Neovascularization; Combined Modality Therapy; Dose-Response Relationship, Drug; Epidemiologic Methods; Female; Fluorescein Angiography; Glucocorticoids; Humans; Macular Degeneration; Male; Photochemotherapy; Treatment Outcome; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity | 2008 |
Combination of photodynamic therapy and intraocular triamcinolone for exudative age-related macular degeneration and long-term chorioretinal macular atrophy.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Atrophy; Choroidal Neovascularization; Chronic Disease; Combined Modality Therapy; Drug Administration Routes; Female; Fluorescein Angiography; Follow-Up Studies; Humans; Macular Degeneration; Male; Middle Aged; Photochemotherapy; Prospective Studies; Retina; Risk Assessment; Sensitivity and Specificity; Severity of Illness Index; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2008 |
Photodynamic therapy and intravitreal triamcinolone for neovascular age-related macular degeneration: a randomized clinical trial.
Topics: Aged; Aged, 80 and over; Choroidal Neovascularization; Double-Blind Method; Drug Therapy, Combination; Female; Fluorescein Angiography; Glucocorticoids; Humans; Injections; Macular Degeneration; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Porphyrins; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Verteporfin; Visual Acuity; Vitreous Body | 2009 |
Changes in macular sensitivity after reduced fluence photodynamic therapy combined with intravitreal triamcinolone.
Topics: Aged; Aged, 80 and over; Choroidal Neovascularization; Combined Modality Therapy; Contrast Sensitivity; Double-Blind Method; Fluorescein Angiography; Glucocorticoids; Humans; Intravitreal Injections; Macular Degeneration; Middle Aged; Photochemotherapy; Photosensitizing Agents; Pilot Projects; Porphyrins; Prospective Studies; Retina; Treatment Outcome; Triamcinolone Acetonide; Verteporfin; Visual Acuity; Visual Field Tests | 2011 |
[Triple therapy for the treatment of choroidal neovascularization with pigment epithelium detachment in age-related macular degeneration].
Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Choroidal Neovascularization; Combined Modality Therapy; Female; Humans; Intravitreal Injections; Macular Degeneration; Male; Photochemotherapy; Prospective Studies; Ranibizumab; Retinal Detachment; Triamcinolone Acetonide | 2010 |
A trial of topical prednisolone acetate before intravitreal triamcinolone acetonide decreases intraocular pressure spikes.
Topics: Administration, Topical; Aged; Choroidal Neovascularization; Follow-Up Studies; Glucocorticoids; Humans; Immunosuppressive Agents; Injections; Intraocular Pressure; Macular Edema; Ocular Hypertension; Ophthalmic Solutions; Prednisolone; Retrospective Studies; Tonometry, Ocular; Triamcinolone Acetonide; Vitreous Body | 2010 |
A randomized clinical trial of a single dose of intravitreal triamcinolone acetonide for neovascular age-related macular degeneration: one-year results.
Topics: Aged; Choroidal Neovascularization; Double-Blind Method; Female; Fluorescein Angiography; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Degeneration; Male; Prospective Studies; Safety; Triamcinolone Acetonide; Vision Disorders; Visual Acuity; Vitreous Body | 2003 |
Combined photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide for choroidal neovascularization.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Choroidal Neovascularization; Drug Therapy, Combination; Female; Fluorescein Angiography; Humans; Injections; Macular Degeneration; Male; Photochemotherapy; Photosensitizing Agents; Pilot Projects; Porphyrins; Prospective Studies; Treatment Outcome; Triamcinolone Acetonide; Verteporfin; Visual Acuity; Vitreous Body | 2003 |
Intravitreal reinjection of triamcinolone for exudative age-related macular degeneration.
Topics: Aged; Aged, 80 and over; Choroidal Neovascularization; Exudates and Transudates; Female; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Degeneration; Male; Middle Aged; Prospective Studies; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2004 |
Safety of an intravitreal injection of triamcinolone: results from a randomized clinical trial.
Topics: Aged; Aged, 80 and over; Cataract; Choroidal Neovascularization; Double-Blind Method; Female; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Degeneration; Male; Middle Aged; Prospective Studies; Safety; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2004 |
Indocyanine green-mediated photothrombosis with intravitreal triamcinolone acetonide for subfoveal choroidal neovascularization in age-related macular degeneration.
Topics: Aged; Aged, 80 and over; Choroidal Neovascularization; Coloring Agents; Combined Modality Therapy; Female; Fluorescein Angiography; Glucocorticoids; Humans; Indocyanine Green; Injections; Lasers; Macular Degeneration; Male; Middle Aged; Photochemotherapy; Tomography, Optical Coherence; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2005 |
Intereye difference in exudative age-related macular degeneration with minimally classic or occult subfoveal neovascularization after unilateral intravitreal injection of triamcinolone acetonide.
Topics: Aged; Aged, 80 and over; Choroidal Neovascularization; Exudates and Transudates; Female; Fovea Centralis; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Degeneration; Male; Middle Aged; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2005 |
Indocyanine green-mediated photothrombosis with and without intravitreal triamcinolone acetonide for subfoveal choroidal neovascularization in age-related macular degeneration: a pilot study.
Topics: Aged; Aged, 80 and over; Choroidal Neovascularization; Coloring Agents; Combined Modality Therapy; Embolization, Therapeutic; Feasibility Studies; Female; Fluorescein Angiography; Fovea Centralis; Glucocorticoids; Humans; Indocyanine Green; Injections; Macular Degeneration; Male; Middle Aged; Pilot Projects; Prospective Studies; Tomography, Optical Coherence; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2005 |
Intravitreal triamcinolone with transpupillary therapy for subfoveal choroidal neovascularization in age related macular degeneration. A randomized controlled pilot study [ISRCTN74123635].
Topics: Aged; Choroidal Neovascularization; Combined Modality Therapy; Glucocorticoids; Humans; Hyperthermia, Induced; Injections; Macular Degeneration; Pilot Projects; Prospective Studies; Pupil; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2005 |
The use of subretinal triamcinolone acetonide in the management of neovascular age-related macular degeneration: a pilot study.
Topics: Choroidal Neovascularization; Combined Modality Therapy; Electroretinography; Fluorescein Angiography; Glucocorticoids; Humans; Indocyanine Green; Injections; Macular Degeneration; Pilot Projects; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitrectomy | 2005 |
Combined photodynamic therapy and intravitreal triamcinolone injection for the treatment of choroidal neovascularisation secondary to pathological myopia: a pilot study.
Topics: Adult; Aged; Aged, 80 and over; Choroidal Neovascularization; Combined Modality Therapy; Epidemiologic Methods; Female; Glucocorticoids; Humans; Injections; Male; Middle Aged; Myopia, Degenerative; Photochemotherapy; Prognosis; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2007 |
Photodynamic therapy with intravitreal triamcinolone in predominantly classic choroidal neovascularization: one-year results of a randomized study.
Topics: Aged; Choroidal Neovascularization; Drug Therapy, Combination; Female; Fluorescein Angiography; Follow-Up Studies; Glucocorticoids; Humans; Injections; Macular Degeneration; Male; Photochemotherapy; Photosensitizing Agents; Porphyrins; Prospective Studies; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Verteporfin; Visual Acuity; Vitreous Body | 2006 |
Optical coherence tomography analysis of a randomized study combining photodynamic therapy with intravitreal triamcinolone.
Topics: Choroidal Neovascularization; Drug Therapy, Combination; Fluorescein Angiography; Glucocorticoids; Humans; Injections; Macular Degeneration; Middle Aged; Photochemotherapy; Photosensitizing Agents; Porphyrins; Prospective Studies; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Verteporfin; Visual Acuity; Vitreous Body | 2008 |
Periocular triamcinolone and photodynamic therapy for subfoveal choroidal neovascularization in age-related macular degeneration.
Topics: Aged; Capillary Permeability; Choroidal Neovascularization; Female; Fluorescein; Fluorescein Angiography; Fluorescent Dyes; Fovea Centralis; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Degeneration; Male; Photochemotherapy; Photosensitizing Agents; Porphyrins; Triamcinolone Acetonide; Verteporfin; Visual Acuity; Vitreous Body | 2007 |
Triamcinolone acetonide as adjunctive treatment to verteporfin in neovascular age-related macular degeneration: a prospective randomized trial.
Topics: Aged; Aged, 80 and over; Cataract; Chemotherapy, Adjuvant; Choroidal Neovascularization; Contrast Sensitivity; Female; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Degeneration; Male; Photochemotherapy; Photosensitizing Agents; Pilot Projects; Porphyrins; Prospective Studies; Retina; Retreatment; Tomography, Optical Coherence; Triamcinolone Acetonide; Verteporfin; Visual Acuity; Vitreous Body | 2007 |
Exudative macular degeneration and intravitreal triamcinolone: 18 month follow up.
Topics: Aged; Aged, 80 and over; Choroidal Neovascularization; Exudates and Transudates; Female; Follow-Up Studies; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Degeneration; Male; Safety; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 1998 |
Intravitreal triamcinolone acetonide in exudative age-related macular degeneration.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Choroidal Neovascularization; Female; Fluorescein Angiography; Humans; Injections; Intraocular Pressure; Macular Degeneration; Male; Middle Aged; Pilot Projects; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2000 |
Exudative macular degeneration and intravitreal triamcinolone. A pilot study.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Case-Control Studies; Choroidal Neovascularization; Exudates and Transudates; Female; Fluorescein Angiography; Humans; Injections; Macular Degeneration; Male; Pilot Projects; Prospective Studies; Safety; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 1995 |
84 other study(ies) available for triamcinolone acetonide and Choroid Neovascularization
| Article | Year |
|---|---|
Retrobulbar triamcinolone for inflammatory choroidal neovascularization in pregnancy.
Topics: Adult; Choroid; Choroidal Neovascularization; Female; Glucocorticoids; Humans; Intravitreal Injections; Pregnancy; Triamcinolone Acetonide | 2020 |
CLINICAL FINDINGS IN TRIAMCINOLONE-ASSOCIATED MACULOPATHY.
Topics: Aged; Aged, 80 and over; Choroidal Neovascularization; Crystallization; Diabetic Retinopathy; Female; Follow-Up Studies; Glucocorticoids; Humans; Intravitreal Injections; Macular Edema; Male; Microscopy, Electron, Transmission; Middle Aged; Retina; Retinal Diseases; Retinal Vein Occlusion; Retrospective Studies; Tomography, Optical Coherence; Triamcinolone Acetonide | 2019 |
Periocular triamcinolone acetonide injection for treating polypoidal choroidal vasculopathy concurrent with hemorrhagic retinal detachment.
Topics: Aged; Angiogenesis Inhibitors; Choroid; Choroid Diseases; Choroidal Neovascularization; Female; Glucocorticoids; Humans; Injections, Intraocular; Intravitreal Injections; Male; Middle Aged; Retinal Detachment; Retinal Hemorrhage; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity | 2018 |
Rare Complication of Sclerochoroidal Calcifications.
Topics: Aged; Angiogenesis Inhibitors; Calcinosis; Calcium; Choroid Diseases; Choroidal Neovascularization; Coloring Agents; Epiretinal Membrane; Female; Fluorescein Angiography; Glucocorticoids; Humans; Indocyanine Green; Macular Edema; Parathyroid Hormone; Retinal Drusen; Scleral Diseases; Tomography, Optical Coherence; Triamcinolone Acetonide; Ultrasonography; Vision Disorders; Visual Fields; Vitamin D | 2019 |
Objective area measurement technique for choroidal neovascularization from fluorescein angiography.
Topics: Animals; Bruch Membrane; Choroidal Neovascularization; Dexamethasone; Fluorescein; Fluorescein Angiography; Humans; Hydrogels; Image Processing, Computer-Assisted; Intravitreal Injections; Lasers; Macular Degeneration; Male; Nanospheres; Rats; Rats, Long-Evans; Triamcinolone Acetonide | 2014 |
The effect of triamcinolone acetonide on laser-induced choroidal neovascularization in mice using a hypoxia visualization bio-imaging probe.
Topics: Animals; Choroidal Neovascularization; Disease Models, Animal; Electroretinography; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Lasers; Male; Mice; Mice, Inbred C57BL; Molecular Probes; Oxygen; Protein Structure, Tertiary; Proteolysis; Rhodamines; Triamcinolone Acetonide | 2015 |
Combination treatment with reduced-fluence photodynamic therapy and intravitreal injection of triamcinolone for subfoveal choroidal neovascularization in macular degeneration.
Topics: Choroidal Neovascularization; Combined Modality Therapy; Dose-Response Relationship, Drug; Glucocorticoids; Humans; Injections; Macular Degeneration; Photochemotherapy; Photosensitizing Agents; Porphyrins; Retrospective Studies; Treatment Outcome; Triamcinolone Acetonide; Verteporfin; Visual Acuity; Vitreous Body | 2008 |
Photodynamic therapy with intravitreal application of triamcinolone acetonide in age-related macular degeneration: functional results in 54 patients.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Choroidal Neovascularization; Drug Synergism; Female; Humans; Injections; Macular Degeneration; Male; Middle Aged; Photochemotherapy; Retrospective Studies; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2009 |
Bevacizumab treatment for subfoveal choroidal neovascularization from causes other than age-related macular degeneration.
Topics: Adult; Angiogenesis Inhibitors; Angioid Streaks; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Choroidal Neovascularization; Choroiditis; Drug Therapy, Combination; Female; Follow-Up Studies; Fovea Centralis; Humans; Injections; Macular Degeneration; Male; Middle Aged; Myopia, Degenerative; Photochemotherapy; Retrospective Studies; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity; Vitreous Body | 2008 |
Comparing pegaptanib and triamcinolone efficacy in the rat choroidal neovascularization model.
Topics: Angiogenesis Inhibitors; Animals; Aptamers, Nucleotide; Choroidal Neovascularization; Disease Models, Animal; Fluorescein Angiography; Glucocorticoids; Injections; Laser Coagulation; Male; Rats; Rats, Inbred BN; Treatment Outcome; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Vitreous Body | 2008 |
Intravitreal bevacizumab for choroidal neovascularization in toxoplasmosis.
Topics: Adult; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Choroidal Neovascularization; Choroiditis; Female; Humans; Injections; Photochemotherapy; Recurrence; Retinitis; Toxoplasmosis; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2009 |
Photodynamic therapy combined with low-dose intravitreal triamcinolone acetonide for age-related macular degeneration refractory to photodynamic therapy alone.
Topics: Aged; Aged, 80 and over; Choroidal Neovascularization; Combined Modality Therapy; Dose-Response Relationship, Drug; Female; Fluorescein Angiography; Glucocorticoids; Humans; Intraocular Pressure; Macular Degeneration; Male; Middle Aged; Photochemotherapy; Porphyrins; Retreatment; Retrospective Studies; Tomography, Optical Coherence; Triamcinolone Acetonide; Verteporfin; Visual Acuity | 2008 |
Time-course and characteristic morphology of retinal changes following combination of verteporfin therapy and intravitreal triamcinolone in neovascular age-related macular degeneration.
Topics: Choroidal Neovascularization; Combined Modality Therapy; Exudates and Transudates; Fluorescein Angiography; Glucocorticoids; Humans; Injections; Macular Degeneration; Photochemotherapy; Photosensitizing Agents; Porphyrins; Retina; Retrospective Studies; Time Factors; Tomography, Optical Coherence; Triamcinolone Acetonide; Verteporfin; Visual Acuity; Vitreous Body | 2010 |
[Evaluation of visual function among patients with exudative AMD treated with an intravitreal injection of triamcinolone acetonide].
Topics: Anti-Inflammatory Agents; Choroidal Neovascularization; Fluorescein Angiography; Humans; Macular Degeneration; Retinal Neovascularization; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity | 2008 |
Secondary elevated IOP and cataracts after high-dose intravitreal triamcinolone and photodynamic therapy to treat choroidal neovascularization.
Topics: Aged; Aged, 80 and over; Antihypertensive Agents; Cataract; Cataract Extraction; Choroidal Neovascularization; Combined Modality Therapy; Female; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Degeneration; Male; Middle Aged; Ocular Hypertension; Photochemotherapy; Retrospective Studies; Triamcinolone Acetonide; Vitreous Body | 2009 |
Focal macular electroretinograms after photodynamic therapy combined with posterior juxtascleral triamcinolone acetonide.
Topics: Aged; Choroidal Neovascularization; Coloring Agents; Combined Modality Therapy; Electroretinography; Female; Fluorescein Angiography; Glucocorticoids; Humans; Indocyanine Green; Injections; Macula Lutea; Macular Degeneration; Male; Photochemotherapy; Photosensitizing Agents; Porphyrins; Sclera; Tomography, Optical Coherence; Triamcinolone Acetonide; Verteporfin | 2009 |
Early effects of intravitreal triamcinolone acetonide on inflammation and proliferation in human choroidal neovascularization.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Choroidal Neovascularization; Combined Modality Therapy; E-Selectin; Female; Humans; Immunoenzyme Techniques; Inflammation; Injections; Intercellular Adhesion Molecule-1; Laser Coagulation; Leukocyte Common Antigens; Leukocyte Count; Leukocytes; Lymphocyte Activation; Macrophages; Macular Degeneration; Male; Middle Aged; Photochemotherapy; Retina; Retrospective Studies; Thy-1 Antigens; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Vitreous Body | 2009 |
Bilateral simultaneous intravitreal injections in the office setting.
Topics: Aged; Angiogenesis Inhibitors; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Choroidal Neovascularization; Dexamethasone; Diabetic Retinopathy; Drug Therapy, Combination; Functional Laterality; Humans; Injections; Intraoperative Complications; Macular Degeneration; Macular Edema; Office Visits; Postoperative Complications; Ranibizumab; Retinal Vein Occlusion; Retrospective Studies; Treatment Outcome; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity; Vitreous Body | 2009 |
Intravitreal bevacizumab vs sub-tenon triamcinolone acetonide for choroidal neovascularization attributable to pathologic myopia.
Topics: Adult; Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Choroidal Neovascularization; Connective Tissue; Female; Follow-Up Studies; Glucocorticoids; Humans; Injections; Male; Middle Aged; Myopia, Degenerative; Retreatment; Retrospective Studies; Treatment Outcome; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity; Vitreous Body; Young Adult | 2009 |
Combined intravitreal pharmacosurgery in patients with occult choroidal neovascularization secondary to wet age-related macular degeneration.
Topics: Acetates; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Choroidal Neovascularization; Combined Modality Therapy; Drug Combinations; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Injections; Male; Middle Aged; Minerals; Pilot Projects; Prospective Studies; Sodium Chloride; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity; Vitrectomy; Vitreous Body; Wet Macular Degeneration | 2010 |
Effect of photodynamic therapy alone or combined with posterior subtenon triamcinolone acetonide or intravitreal bevacizumab on choroidal hypofluorescence by indocyanine green angiography.
Topics: Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Choroid; Choroidal Neovascularization; Coloring Agents; Drug Therapy, Combination; Female; Fluorescein Angiography; Glucocorticoids; Humans; Indocyanine Green; Injections; Macular Degeneration; Male; Photochemotherapy; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity; Vitreous Body | 2010 |
Intravitreal injection of triamcinolone combined with bevacizumab for choroidal neovascularization associated with large retinal pigment epithelial detachment in age-related macular degeneration.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Choroidal Neovascularization; Coloring Agents; Drug Therapy, Combination; Female; Fluorescein Angiography; Follow-Up Studies; Glucocorticoids; Humans; Indocyanine Green; Injections; Macular Degeneration; Male; Middle Aged; Prognosis; Prospective Studies; Retinal Detachment; Retinal Pigment Epithelium; Retreatment; Tomography, Optical Coherence; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity; Vitreous Body | 2010 |
Polypoidal choroidal vasculopathy in a patient with angioid streaks secondary to pseudoxanthoma elasticum.
Topics: Angioid Streaks; Choroid; Choroid Diseases; Choroidal Neovascularization; Combined Modality Therapy; Female; Fluorescein Angiography; Humans; Indocyanine Green; Middle Aged; Peripheral Vascular Diseases; Photochemotherapy; Pseudoxanthoma Elasticum; Retinal Pigment Epithelium; Triamcinolone Acetonide; Visual Acuity | 2010 |
Cytomegalovirus retinitis after subtenon triamcinolone acetonide and intravitreal injection of anti-vascular endothelial growth factor in an immunocompetent patient with age-related macular degeneration and diabetes mellitus.
Topics: Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Choroidal Neovascularization; Cytomegalovirus Retinitis; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Fascia; Glucocorticoids; Humans; Immunocompromised Host; Injections; Macular Degeneration; Male; Tomography, Optical Coherence; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Vitrectomy; Vitreous Body | 2010 |
Inhibition of choroidal neovascularization by intravitreal ketorolac.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Capillary Permeability; Choroidal Neovascularization; Disease Models, Animal; Fluorescein Angiography; Glucocorticoids; Injections; Ketorolac; Macular Degeneration; Male; Rats; Rats, Inbred BN; Triamcinolone Acetonide; Vitreous Body | 2010 |
Improved assessment of laser-induced choroidal neovascularization.
Topics: Animals; Bruch Membrane; Choroidal Neovascularization; Cyclooxygenase Inhibitors; Disease Models, Animal; Fluorescein Angiography; Glucocorticoids; Image Interpretation, Computer-Assisted; Intravitreal Injections; Ketorolac; Lasers, Gas; Male; Microscopy, Fluorescence; Rats; Rats, Inbred BN; Reproducibility of Results; Software; Specimen Handling; Time Factors; Triamcinolone Acetonide | 2010 |
Intravitreal triamcinolone, bevacizumab and pegaptanib for occult choroidal neovascularization.
Topics: Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Aptamers, Nucleotide; Bevacizumab; Choroidal Neovascularization; Female; Fluorescein Angiography; Follow-Up Studies; Fovea Centralis; Glucocorticoids; Humans; Intraocular Pressure; Intravitreal Injections; Macular Degeneration; Male; Prognosis; Retreatment; Retrospective Studies; Tomography, Optical Coherence; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity | 2010 |
Color Doppler imaging of ocular blood flow after combined photodynamic therapy with intravitreal triamcinolone in age-related macular degeneration.
Topics: Aged; Aged, 80 and over; Blood Flow Velocity; Choroidal Neovascularization; Ciliary Arteries; Combined Modality Therapy; Female; Glucocorticoids; Humans; Intravitreal Injections; Macular Degeneration; Male; Middle Aged; Ophthalmic Artery; Photochemotherapy; Photosensitizing Agents; Porphyrins; Regional Blood Flow; Retinal Artery; Triamcinolone Acetonide; Ultrasonography, Doppler, Color; Verteporfin; Visual Acuity | 2011 |
[Efficacy of three intravitreal injections of bevacizumab in the treatment of exudative age-related macular degeneration].
Topics: Aged; Angiogenesis Inhibitors; Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Bevacizumab; Choroidal Neovascularization; Endophthalmitis; Fluorescein Angiography; Follow-Up Studies; Glucocorticoids; Humans; Intravitreal Injections; Macula Lutea; Macular Edema; Photochemotherapy; Pigment Epithelium of Eye; Retinal Detachment; Retinal Hemorrhage; Retinal Perforations; Retrospective Studies; Subretinal Fluid; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity; Vitreous Hemorrhage; Wet Macular Degeneration | 2011 |
Vascularized retinal pigment epithelial detachment in age-related macular degeneration: treatment and RPE tear incidence.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Choroidal Neovascularization; Combined Modality Therapy; Female; Fluorescein Angiography; Glucocorticoids; Humans; Indocyanine Green; Intravitreal Injections; Macular Degeneration; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Porphyrins; Ranibizumab; Retinal Detachment; Retinal Neovascularization; Retinal Perforations; Retinal Pigment Epithelium; Retrospective Studies; Tomography, Optical Coherence; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Verteporfin; Visual Acuity | 2012 |
RETRACTED: Influence of choroidal neovascularization and biodegradable polymeric particle size on transscleral sustained delivery of triamcinolone acetonide.
Topics: Administration, Ophthalmic; Animals; Cell Line; Choroidal Neovascularization; Delayed-Action Preparations; Drug Carriers; Drug Delivery Systems; Emulsions; Glucocorticoids; Humans; Inhibitory Concentration 50; Male; Microspheres; Nanoparticles; Particle Size; Polyesters; Rats; Rats, Inbred BN; Retinal Pigment Epithelium; Sclera; Time Factors; Tissue Distribution; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A | 2012 |
Bevacizumab and triamcinolone acetonide for choroidal neovascularization due to age-related macular degeneration unresponsive to antivascular endothelial growth factors.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Bevacizumab; Choroidal Neovascularization; Drug Therapy, Combination; Female; Fluorescein Angiography; Follow-Up Studies; Humans; Intravitreal Injections; Macular Degeneration; Male; Middle Aged; Retrospective Studies; Time Factors; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity | 2013 |
Choroidal neovascular membrane inhibition in a laser treated rat model with intraocular sustained release triamcinolone acetonide microimplants.
Topics: Animals; Anti-Inflammatory Agents; Choroidal Neovascularization; Disease Models, Animal; Drug Administration Schedule; Drug Implants; Glucocorticoids; Laser Coagulation; Male; Rats; Rats, Inbred BN; Triamcinolone Acetonide | 2003 |
Intravitreal triamcinolone for choroidal neovascularization in ocular histoplasmosis syndrome.
Topics: Adult; Choroidal Neovascularization; Eye Infections, Fungal; Female; Fluorescein Angiography; Follow-Up Studies; Glucocorticoids; Histoplasmosis; Humans; Injections; Male; Middle Aged; Retrospective Studies; Syndrome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2003 |
Pseudohypopyon following intravitreal triamcinolone acetonide injection.
Topics: Anterior Eye Segment; Choroidal Neovascularization; Endophthalmitis; Female; Glucocorticoids; Humans; Injections; Middle Aged; Remission, Spontaneous; Triamcinolone Acetonide; Vitreous Body | 2004 |
Trans-Tenon's retrobulbar triamcinolone infusion for small choroidal neovascularisation.
Topics: Anti-Inflammatory Agents; Choroidal Neovascularization; Fluorescein Angiography; Humans; Treatment Outcome; Triamcinolone Acetonide | 2004 |
Retinal angiomatous proliferation: clinical characteristics and treatment options.
Topics: Aged; Aged, 80 and over; Angiomatosis; Choroidal Neovascularization; Combined Modality Therapy; Female; Fluorescein Angiography; Humans; Indocyanine Green; Macular Degeneration; Photochemotherapy; Retinal Neovascularization; Tomography, Optical Coherence; Triamcinolone Acetonide | 2004 |
Photodynamic therapy with verteporfin combined with intravitreal injection of triamcinolone acetonide for choroidal neovascularization.
Topics: Aged; Choroidal Neovascularization; Drug Therapy, Combination; Fluorescein Angiography; Glucocorticoids; Humans; Injections; Macular Degeneration; Photochemotherapy; Photosensitizing Agents; Pilot Projects; Porphyrins; Prospective Studies; Triamcinolone Acetonide; Verteporfin; Visual Acuity; Vitreous Body | 2005 |
Persistent depot of triamcinolone acetonide after a single intravitreal injection.
Topics: Aged; Choroidal Neovascularization; Delayed-Action Preparations; Fluorescein Angiography; Fundus Oculi; Glucocorticoids; Humans; Injections; Male; Retinal Hemorrhage; Triamcinolone Acetonide; Vitreous Body | 2005 |
Suppression of laser-induced choroidal neovascularization by posterior sub-tenon administration of triamcinolone acetonide.
Topics: Animals; Capillary Permeability; Choroidal Neovascularization; Chromatography, High Pressure Liquid; Connective Tissue; Disease Models, Animal; Fluorescein Angiography; Glucocorticoids; Laser Coagulation; Male; Rats; Rats, Inbred BN; Triamcinolone Acetonide | 2005 |
Cataract progression after intravitreal triamcinolone injection.
Topics: Aged; Aged, 80 and over; Cataract; Choroidal Neovascularization; Disease Progression; Female; Follow-Up Studies; Glucocorticoids; Humans; Injections; Lens, Crystalline; Male; Middle Aged; Retinal Diseases; Retrospective Studies; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2005 |
Combined photodynamic therapy and intravitreal triamcinolone for nonsubfoveal choroidal neovascularization.
Topics: Aged; Aged, 80 and over; Choroidal Neovascularization; Combined Modality Therapy; Female; Fluorescein Angiography; Glucocorticoids; Humans; Injections; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Pilot Projects; Porphyrins; Retreatment; Triamcinolone Acetonide; Verteporfin; Visual Acuity; Vitreous Body | 2005 |
Complications of intravitreal steroid injections.
Topics: Aged; Aged, 80 and over; Antihypertensive Agents; Choroidal Neovascularization; Glaucoma; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Edema; Male; Ocular Hypertension; Photochemotherapy; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2005 |
Combined photodynamic therapy and intravitreal triamcinolone for the treatment of myopic choroidal neovascularization in a 13-year-old girl.
Topics: Adolescent; Choroidal Neovascularization; Drug Therapy, Combination; Female; Fluorescein Angiography; Glucocorticoids; Humans; Myopia, Degenerative; Photochemotherapy; Photosensitizing Agents; Porphyrins; Treatment Outcome; Triamcinolone Acetonide; Verteporfin; Visual Acuity | 2006 |
Photodynamic therapy in combination with intravitreal triamcinolone for myopic choroidal neovascularization.
Topics: Adult; Choroidal Neovascularization; Drug Therapy, Combination; Fluorescein Angiography; Glucocorticoids; Humans; Injections; Male; Myopia, Degenerative; Photochemotherapy; Photosensitizing Agents; Porphyrins; Treatment Outcome; Triamcinolone Acetonide; Verteporfin; Visual Acuity; Vitreous Body | 2005 |
Effect of posterior juxtascleral triamcinolone acetonide on choroidal neovascular growth after photodynamic therapy with verteporfin.
Topics: Aged; Aged, 80 and over; Chemotherapy, Adjuvant; Choroidal Neovascularization; Connective Tissue; Female; Fluorescein Angiography; Glucocorticoids; Humans; Injections; Macular Degeneration; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Porphyrins; Sclera; Treatment Outcome; Triamcinolone Acetonide; Verteporfin; Visual Acuity | 2005 |
A new treatment regimen in combined intravitreal injection of triamcinolone acetonide and photodynamic therapy.
Topics: Aged; Aged, 80 and over; Choroidal Neovascularization; Combined Modality Therapy; Female; Fluorescein Angiography; Glucocorticoids; Humans; Indocyanine Green; Injections; Macular Degeneration; Male; Photochemotherapy; Prospective Studies; Retinal Neovascularization; Tomography, Optical Coherence; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2006 |
Verteporfin therapy combined with intravitreal triamcinolone in all types of choroidal neovascularization due to age-related macular degeneration.
Topics: Aged; Choroidal Neovascularization; Combined Modality Therapy; Drug Therapy, Combination; Female; Fluorescein Angiography; Glucocorticoids; Humans; Injections; Macular Degeneration; Male; Photochemotherapy; Photosensitizing Agents; Porphyrins; Retreatment; Treatment Outcome; Triamcinolone Acetonide; Verteporfin; Visual Acuity; Vitreous Body | 2006 |
Occult with no classic choroidal neovascularization secondary to age-related macular degeneration treated by intravitreal triamcinolone and photodynamic therapy with verteporfin.
Topics: Aged; Aged, 80 and over; Choroidal Neovascularization; Drug Therapy, Combination; Female; Fluorescein Angiography; Glucocorticoids; Humans; Injections; Macular Degeneration; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Porphyrins; Prospective Studies; Tomography, Optical Coherence; Triamcinolone Acetonide; Verteporfin; Visual Acuity; Vitreous Body | 2006 |
Follow-up after intravitreal triamcinolone acetonide for exudative age-related macular degeneration.
Topics: Aged; Aged, 80 and over; Choroidal Neovascularization; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Degeneration; Middle Aged; Prospective Studies; Time Factors; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2007 |
Retinal pigment epithelium tears following verteporfin therapy combined with intravitreal triamcinolone.
Topics: Choroidal Neovascularization; Drug Therapy, Combination; Fluorescein Angiography; Glucocorticoids; Humans; Injections; Macular Degeneration; Photochemotherapy; Photosensitizing Agents; Pigment Epithelium of Eye; Porphyrins; Prospective Studies; Retinal Perforations; Tomography, Optical Coherence; Triamcinolone Acetonide; Verteporfin; Visual Acuity; Vitreous Body | 2006 |
[Sub-Tenon's injection of triamcinolone acetonide for choroidal neovascularization].
Topics: Aged; Choroidal Neovascularization; Female; Glucocorticoids; Humans; Injections; Male; Middle Aged; Triamcinolone Acetonide; Visual Acuity | 2006 |
Ptosis following an intravitreal injection of triamcinolone acetonide.
Topics: Aged; Blepharoptosis; Choroidal Neovascularization; Female; Glucocorticoids; Humans; Injections; Macular Degeneration; Male; Triamcinolone Acetonide; Vitreous Body | 2007 |
Verteporfin and intravitreal triamcinolone acetonide combination therapy for occult choroidal neovascularization in age-related macular degeneration.
Topics: Aged; Aged, 80 and over; Antihypertensive Agents; Cataract Extraction; Choroidal Neovascularization; Drug Therapy, Combination; Female; Fluorescein Angiography; Glucocorticoids; Humans; Intraocular Pressure; Macular Degeneration; Male; Photochemotherapy; Photosensitizing Agents; Porphyrins; Prospective Studies; Retreatment; Treatment Outcome; Triamcinolone Acetonide; Verteporfin; Visual Acuity | 2006 |
Photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide in the treatment of neovascular age-related macular degeneration.
Topics: Aged; Choroidal Neovascularization; Drug Therapy, Combination; Female; Follow-Up Studies; Glucocorticoids; Humans; Injections; Macular Degeneration; Male; Photochemotherapy; Photosensitizing Agents; Porphyrins; Retreatment; Retrospective Studies; Triamcinolone Acetonide; Verteporfin; Visual Acuity; Vitreous Body | 2006 |
Combined photodynamic therapy and intravitreal triamcinolone acetonide for the treatment of myopic subfoveal choroidal neovascularization.
Topics: Adult; Aged; Choroidal Neovascularization; Drug Therapy, Combination; Fluorescein Angiography; Glucocorticoids; Humans; Injections; Intraocular Pressure; Middle Aged; Myopia, Degenerative; Photochemotherapy; Photosensitizing Agents; Porphyrins; Prospective Studies; Triamcinolone Acetonide; Verteporfin; Visual Acuity; Vitreous Body | 2006 |
Combination therapy for choroidal neovascularization.
Topics: Choroidal Neovascularization; Drug Therapy, Combination; Glucocorticoids; Humans; Photochemotherapy; Triamcinolone Acetonide | 2006 |
Choroidal neovascular membrane in radiation retinopathy.
Topics: Adult; Choroidal Neovascularization; Fluorescein Angiography; Glucocorticoids; Humans; Injections; Macular Edema; Male; Nasopharyngeal Neoplasms; Radiation Injuries; Retina; Tomography, Optical Coherence; Triamcinolone Acetonide; Vitreous Body | 2006 |
Evolving European guidance on the medical management of neovascular age related macular degeneration.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Aptamers, Nucleotide; Choroidal Neovascularization; Evidence-Based Medicine; Humans; Macular Degeneration; Photochemotherapy; Pregnadienediols; Ranibizumab; Treatment Outcome; Triamcinolone Acetonide | 2006 |
Combination photodynamic therapy and juxtascleral triamcinolone acetonide for the treatment of a peripapillary choroidal neovascular membrane associated with papilloedema.
Topics: Adult; Choroidal Neovascularization; Female; Glucocorticoids; Humans; Papilledema; Photochemotherapy; Triamcinolone Acetonide | 2006 |
Trans-Tenon's retrobulbar triamcinolone infusion for myopic choroidal neovascularization.
Topics: Adult; Aged; Choroidal Neovascularization; Fascia; Female; Fluorescein Angiography; Glucocorticoids; Humans; Infusions, Parenteral; Male; Middle Aged; Myopia, Degenerative; Orbit; Tomography, Optical Coherence; Triamcinolone Acetonide; Visual Acuity | 2006 |
Combination therapy of intravitreal triamcinolone and photodynamic therapy with verteporfin for subfoveal choroidal neovascularization.
Topics: Aged; Choroidal Neovascularization; Drug Therapy, Combination; Female; Fluorescein Angiography; Follow-Up Studies; Fovea Centralis; Fundus Oculi; Glucocorticoids; Humans; Injections; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Pilot Projects; Porphyrins; Prospective Studies; Treatment Outcome; Triamcinolone Acetonide; Verteporfin; Vitreous Body | 2006 |
Triple therapy of intravitreal triamcinolone, photodynamic therapy, and pegaptanib sodium for choroidal neovascularization.
Topics: Aged, 80 and over; Aptamers, Nucleotide; Choroidal Neovascularization; Drug Therapy, Combination; Fluorescein Angiography; Glucocorticoids; Humans; Injections; Photochemotherapy; Photosensitizing Agents; Porphyrins; Retrospective Studies; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Verteporfin; Visual Acuity; Vitreous Body | 2006 |
Combined photodynamic therapy and intravitreal triamcinolone injection for the treatment of choroidal neovascularisation secondary to pathological myopia: a pilot study.
Topics: Choroidal Neovascularization; Combined Modality Therapy; Glucocorticoids; Humans; Myopia, Degenerative; Photochemotherapy; Pilot Projects; Triamcinolone Acetonide | 2007 |
Intravitreal bevacizumab for idiopathic choroidal neovascularization after previous injection with posterior subtenon triamcinolone.
Topics: Adolescent; Adult; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Choroidal Neovascularization; Female; Fluorescein Angiography; Glucocorticoids; Humans; Injections; Male; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity; Vitreous Body | 2007 |
Retinal pigment epithelial tear after intravitreal injection of triamcinolone acetonide for neovascular pigment epithelial detachment: a mechanical explanation.
Topics: Aged; Choroidal Neovascularization; Fluorescein Angiography; Glucocorticoids; Humans; Injections; Male; Ophthalmoscopy; Pigment Epithelium of Eye; Retinal Detachment; Retinal Perforations; Triamcinolone Acetonide; Vitreous Body | 2007 |
Evaluation of subretinal triamcinolone acetonide in patients with exudative age-related macular degeneration.
Topics: Aged; Aging; Anti-Inflammatory Agents; Choroidal Neovascularization; Combined Modality Therapy; Electroretinography; Female; Fluorescein Angiography; Humans; Macular Degeneration; Male; Pilot Projects; Retina; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity | 2007 |
Influence of triamcinolone intravitreal injection on retinochoroidal healing processes.
Topics: Animals; Anti-Inflammatory Agents; Apoptosis; Cell Proliferation; Choroidal Neovascularization; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Female; Glucocorticoids; In Situ Nick-End Labeling; Laser Coagulation; Mice; Mice, Inbred C57BL; Triamcinolone Acetonide; Wound Healing | 2007 |
Combined photodynamic therapy and intravitreal triamcinolone for neovascular age-related macular degeneration: effect of initial visual acuity on treatment response.
Topics: Choroidal Neovascularization; Combined Modality Therapy; Follow-Up Studies; Glucocorticoids; Humans; Injections; Macular Degeneration; Photochemotherapy; Photosensitizing Agents; Porphyrins; Retrospective Studies; Treatment Outcome; Triamcinolone Acetonide; Verteporfin; Visual Acuity; Vitreous Body | 2007 |
Indocyanine-green-mediated photothrombosis (IMP) with intravitreal triamcinolone acetonide for macular edema secondary to group 2A idiopathic parafoveal telangiectasis without choroidal neovascularization: a pilot study.
Topics: Aged; Choroidal Neovascularization; Coloring Agents; Combined Modality Therapy; Feasibility Studies; Female; Fluorescein Angiography; Fovea Centralis; Glucocorticoids; Humans; Indocyanine Green; Injections; Macular Edema; Male; Middle Aged; Photochemotherapy; Pilot Projects; Retinal Diseases; Telangiectasis; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2007 |
Low-power transpupillary thermotherapy combined with intravitreal triamcinolone acetonide for subfoveal choroidal neovascularization.
Topics: Choroidal Neovascularization; Follow-Up Studies; Fovea Centralis; Glucocorticoids; Humans; Hyperthermia, Induced; Injections; Pupil; Retreatment; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2007 |
[Position of the Retinological Society, the German Ophthalmological Society and the Professional Association of Ophthalmologists in Germany on the current therapeutic possibilities for neovascular age-related macular degeneration].
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Aptamers, Nucleotide; Bevacizumab; Choroidal Neovascularization; Drug Therapy, Combination; Evidence-Based Medicine; Humans; Macular Degeneration; Ophthalmology; Photochemotherapy; Porphyrins; Pregnadienediols; Ranibizumab; Societies, Medical; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Verteporfin | 2007 |
Retinal angiomatous proliferation: combined therapy of intravitreal triamcinolone acetonide and PDT versus PDT alone.
Topics: Aged; Aged, 80 and over; Choroidal Neovascularization; Drug Therapy, Combination; Female; Fluorescein Angiography; Follow-Up Studies; Glucocorticoids; Humans; Injections; Macular Degeneration; Male; Middle Aged; Photochemotherapy; Prospective Studies; Retinal Neovascularization; Retrospective Studies; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2008 |
Effect of posterior juxtascleral triamcinolone acetonide on the efficacy and choriocapillaris hypoperfusion of photodynamic therapy.
Topics: Aged; Angiogenesis Inhibitors; Choroid; Choroidal Neovascularization; Coloring Agents; Female; Fluorescein Angiography; Glucocorticoids; Humans; Indocyanine Green; Injections; Macular Degeneration; Male; Photochemotherapy; Porphyrins; Retreatment; Tomography, Optical Coherence; Triamcinolone Acetonide; Verteporfin; Visual Acuity; Vitreous Body | 2008 |
Choroidal neovascularization from a presumed subretinal nematode.
Topics: Adult; Choroidal Neovascularization; Drug Therapy, Combination; Eye Infections, Parasitic; Female; Fluorescein Angiography; Glucocorticoids; Humans; Photochemotherapy; Photosensitizing Agents; Porphyrins; Retinal Diseases; Tomography, Optical Coherence; Triamcinolone Acetonide; Verteporfin; Visual Acuity | 2007 |
Combined photodynamic therapy and intravitreal triamcinolone injection for choroidal neovascularization in Best disease.
Topics: Adult; Choroidal Neovascularization; Diagnosis, Differential; Female; Fluorescein Angiography; Follow-Up Studies; Fundus Oculi; Glucocorticoids; Humans; Injections; Photochemotherapy; Photosensitizing Agents; Porphyrins; Retinal Degeneration; Tomography, Optical Coherence; Triamcinolone Acetonide; Verteporfin; Visual Acuity; Vitreous Body | 2007 |
Combined photodynamic therapy and intravitreal triamcinolone for choroidal neovascularization secondary to punctate inner choroidopathy or of idiopathic origin: one-year results of a prospective series.
Topics: Adolescent; Adult; Choroid Diseases; Choroidal Neovascularization; Drug Therapy, Combination; Female; Fluorescein Angiography; Glucocorticoids; Humans; Injections; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Porphyrins; Prospective Studies; Treatment Outcome; Triamcinolone Acetonide; Verteporfin; Visual Acuity; Vitreous Body | 2008 |
Early effects of triamcinolone on vascular endothelial growth factor and endostatin in human choroidal neovascularization.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Antigens, CD34; Choroidal Neovascularization; Drug Therapy, Combination; Endostatins; Female; Humans; Immunoenzyme Techniques; Keratin-18; Macular Degeneration; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Porphyrins; Retrospective Studies; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Verteporfin | 2008 |
Photodynamic therapy combined with posterior subtenon triamcinolone acetonide injection in the treatment of choroidal neovascularization.
Topics: Adult; Aged; Choroidal Neovascularization; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Injections, Intraocular; Male; Middle Aged; Myopia; Photochemotherapy; Retrospective Studies; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity | 2009 |
A prospective study of early intraocular pressure changes after a single intravitreal triamcinolone injection.
Topics: Adult; Aged; Aged, 80 and over; Choroidal Neovascularization; Female; Glucocorticoids; Gonioscopy; Humans; Injections; Intraocular Pressure; Macular Degeneration; Macular Edema; Male; Middle Aged; Prospective Studies; Retinal Vein Occlusion; Triamcinolone Acetonide; Vitreous Body | 2008 |
Secondary ocular hypertension after intravitreal injection of 4 mg of triamcinolone acetonide: incidence and risk factors.
Topics: Adult; Aged; Aged, 80 and over; Choroidal Neovascularization; Female; Glucocorticoids; Humans; Incidence; Injections; Intraocular Pressure; Macular Degeneration; Male; Middle Aged; Ocular Hypertension; Retrospective Studies; Risk Factors; Tonometry, Ocular; Triamcinolone Acetonide; Vitreous Body | 2008 |
Intravitreal triamcinolone acetonide inhibits choroidal neovascularization in a laser-treated rat model.
Topics: Animals; Anti-Inflammatory Agents; Choroidal Neovascularization; Disease Models, Animal; Fluorescein Angiography; Injections; Laser Coagulation; Male; Rats; Rats, Inbred BN; Retinal Vessels; Triamcinolone Acetonide; Vitreous Body | 2001 |
Effects of triamcinolone acetonide on microglial morphology and quantitative expression of MHC-II in exudative age-related macular degeneration.
Topics: Aged; Aged, 80 and over; Choroidal Neovascularization; Down-Regulation; Female; Fluorescein Angiography; Fluorescent Antibody Technique, Indirect; Glucocorticoids; HLA-DR Antigens; Humans; Immunohistochemistry; Injections; Macular Degeneration; Microglia; Microscopy, Confocal; Triamcinolone Acetonide; Vitreous Body | 2001 |
Inhibitory effects of triamcinolone acetonide on bFGF-induced migration and tube formation in choroidal microvascular endothelial cells.
Topics: Animals; Cattle; Cell Movement; Cells, Cultured; Choroid; Choroidal Neovascularization; Dose-Response Relationship, Drug; Down-Regulation; Endothelium, Vascular; Fibroblast Growth Factor 2; Immunosuppressive Agents; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Triamcinolone Acetonide | 2002 |